Remove Biopharma Remove Patients Remove Physicians Remove Specialization
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

article thumbnail

Three Sales Compensation Pitfalls to Avoid for a Rare Disease Product Launch

The Marketing Advantage

May 9, 2023 Since the Orphan Drug Act was passed in 1983, the number of products being researched and approved for rare and orphan diseases has increased dramatically, offering hope and life-saving treatments for the millions of patients affected by these often under-served conditions.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oculis SA and EBAC join to drive ophthalmology innovation

pharmaphorum

Oculis SA, a global biopharmaceutical company that develops treatments for saving sight and improving eye care with breakthrough innovations, is to combine with the European Biotech Acquisition Corp (EBAC), a special purpose acquisition company (SPAC) that has screened over 100 European biotechnology companies.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. The caregiver’s influence on the patient’s adherence, reactions to adverse effects, and treatment persistency can be a game-changer for the brand.

Pharma 98
article thumbnail

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

article thumbnail

Handling Economic Uncertainty: The Focus Pharma Marketers Need

Eversana Intouch

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

article thumbnail

Handling Economic Uncertainy: The Focus Pharma Marketers Need

Eversana Intouch

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.